QA: ENZO BIOCHEM INC in us_health_services/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000316253_2023_ENZO_BIOCHEM_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000316253, ENZO BIOCHEM INC

  xvar xval
0 IntangibleAssets 7,452,000
1 AssetsNonCurrent 16,792,000
2 AssetsCurrent 54,354,000
3 PropertyPlantAndEquipment 17,259,000
4 remainder_Assets 0
5 LongTermLiabilities 16,845,000
6 LiabilitiesCurrent 24,550,000
7 remainder_Liabilities 0
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 65,104,000
10 GeneralAndAdministrativeExpense 48,018,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 3,767,000
16 remainder_Expenses 5,189,000
17 remainder_Revenues 107,071,000
18 remainder_NetIncome -3,254,000
19 remainder_ComprehensiveNetIncome 1,799,000
  yvar yval
0 Assets 95,857,000
1 Liabilities 41,395,000
2 Expenses 122,078,000
3 Revenues 107,071,000
4 StockholdersEquity 54,462,000
5 NetIncome -18,261,000
6 ComprehensiveNetIncome -16,462,000
7 BaseVar 224,370,330
8 EconomicCapitalRatio 1.02

Edgar->Model Mapping

Feature Distribution

Change over Time